Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, and anticonvulsant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor.
## Primary Indications
* **Anxiety Disorders:** Management of anxiety symptoms.
* **Insomnia:** Short-term treatment of insomnia characterized by difficulty in falling asleep.
* **Seizure Disorders:** Management of status epilepticus and other acute seizure activity.
* **Preoperative Medication:** To induce sedation and reduce anxiety before surgery.
## Adult Dosing
* **Anxiety Disorders:** Typically 1-4 mg orally every 8-12 hours. Maximum daily dose generally 10 mg.
* **Insomnia:** 2-4 mg orally at bedtime. Not recommended for long-term use.
* **Status Epilepticus:** 4 mg intravenously (IV) or intramuscularly (IM). Repeat dose of 4 mg may be given after 10-15 minutes if seizures persist. Maximum initial dose generally 8 mg.
* **Preoperative Medication:** 2-4 mg IM or IV approximately 2 hours before surgery.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be based on weight and clinical indication. Consultation with a pediatric specialist or critical care is often recommended.
* **Seizures:** Typically 0.1 mg/kg IV/IM, not to exceed 4 mg per dose. Repeat doses can be considered.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** Use with caution; dose reduction may be necessary.
* **Elderly:** Initiate at lower doses (e.g., 0.5-1 mg twice daily) and titrate slowly, as they may be more sensitive to adverse effects.
## Contraindications
* Known hypersensitivity to lorazepam, other benzodiazepines, or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
* Sleep apnea.
## Adverse Effects
Common: Drowsiness, dizziness, weakness, unsteadiness, fatigue.
Less Common: Confusion, depression, memory impairment, paradoxical reactions (agitation, irritability), respiratory depression, hypotension.
## Key Drug Interactions
* **CNS Depressants (alcohol, opioids, barbiturates, other sedatives):** Additive CNS depression, potentially leading to profound sedation, respiratory depression, coma, and death. Use concurrently with extreme caution and consider dose reduction of one or both agents.
* **Theophylline and Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam plasma concentrations.
## Monitoring
* Assess for sedation, respiratory rate, and oxygen saturation, especially with IV administration or in combination with other CNS depressants.
* Monitor for paradoxical reactions, confusion, and signs of dependence or withdrawal.
* Evaluate effectiveness in treating anxiety or seizures.
## Clinical Pearls
* Lorazepam has a relatively short half-life compared to other benzodiazepines, which may be beneficial for avoiding prolonged sedation but can lead to more frequent dosing.
* Intramuscular (IM) absorption can be variable. IV administration is preferred for more rapid and predictable effect in acute settings like status epilepticus.
* Tolerance and dependence can develop with prolonged use. Tapering of the dose is recommended when discontinuing therapy after extended use to avoid withdrawal symptoms.
***
*This information is intended for healthcare professionals. Always consult the current prescribing information and relevant guidelines before making any clinical decisions.*
